A

Acusurgical

www.acusurgical.com link_icon

Company Research Report



Company Overview



Name and Mission


  • Company Name: AcuSurgical

  • Mission: Creating the new standard of care in retinal surgery by providing surgeons with advanced robotic tools to enhance safety and accessibility in retinal microsurgery.


Founding Details


  • Founded: 2020

  • Founders and Key People:

  • Christoph Spuhler - Co-founder and General Manager, previously CEO

  • Yassine Haddab - Co-founder / Advisor

  • Philippe Poignet - Co-founder / Advisor

  • Gilles Thuret - Co-founder / Scientific Advisor

  • Philippe Gain - Co-founder / Scientific Advisor


Key People


  • CEO: Ronen Castro (joined recently)

  • Chairman: Didier Deltort

  • Board of Directors:

  • Michael Brownell

  • Christoph Spuhler

  • Célia Hart

  • Valérie Calenda

  • Gonzague Issenmann

  • Leadership Team:

  • Pierre-Antoine Forest - Marketing Director

  • Luc Demangeon - Regulatory and Quality Director

  • Magali Brouillat - R&D Manager

  • Michael Brownell - Head of Business Development

  • Véronique Puyau - Chief Financial Officer

  • Hélène Lamielle - Head of Clinical


Headquarters


  • Location: Cap Oméga, Rond-point Benjamin Franklin, 34000 Montpellier, France


Employees and Industry


  • Number of Employees: 11-50

  • Industry: Medical Equipment Manufacturing


Revenue and Recognition


  • Revenue: Specific revenue figures are not available.

  • Recognition: Highlighted by "Challenges" in its prestigious ranking of "100 Start-ups to Invest In in 2024."


Specialization


  • Known For: Developing the world’s first bi-manual/dual-instrument robot for eye surgery, notably the Luca™ surgical robotics platform.


Products



Product Offerings


  • Main Product: Luca™ Surgical Robot


High-Level Description of Product


  • Luca™ Surgical Robot: A high-precision robotics surgical platform designed for vitrectomy procedures, offering precision up to 10 microns. It comprises a console-operated system with two robot arms, each holding an instrument.


Key Features


  • Bimanual/Dual-Instrument Capability: Allows complex eye surgeries with high dexterity.

  • Precision Engineering: Achieves micrometric precision critical for retinal surgeries.

  • Integration into Operating Room Workflows: The system is designed to seamlessly integrate into existing surgical environments.

  • Training and Efficiency: Potential to expedite surgeon training and improve procedural efficiency.


Recent Developments



Clinical Studies and Market Introduction


  • Successful Clinical Study: AcuSurgical has completed its first human clinical trial using the Luca™ system at Ghent University Hospital in Belgium, treating seven patients successfully with retinal disorders.

  • Surgical Milestone: This achievement marks a major milestone in improving treatments for challenging retinal conditions.


Leadership Appointments


  • Recently appointed Ronen Castro as CEO and Didier Deltort as Chairman of the Board, both bringing significant experience in ophthalmology and healthcare technology.


Partnerships


  • Affiliations: Not specified in the data. Partnerships generally sought to advance innovation in ophthalmic robotics.


News and Recognitions


  • Featured in "Challenges": Listed as a top startup to invest in for 2024.

  • CNRS Innovation Support: Recognized for participating in a French academic research ecosystem.


Technological Advancements


  • Robotic Precision: Luca™ system provides precision levels that were previously unattainable, with actionable potential in enhancing the quality and reach of retinal surgeries globally.


Future Prospects


  • Innovation and Expansion Strategy: Under guidance from new leadership, continues to focus on expanding technological capabilities and market reach in ophthalmic surgery.


No further information is available for fields not addressed in this report.